Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer



Shaw, RJ ORCID: 0000-0001-7027-8997, Omar, MM, Rokadiya, S, Kogera, FA, Lowe, D, Hall, GL, Woolgar, JA, Homer, J, Liloglou, T ORCID: 0000-0003-0460-1404, Field, JK ORCID: 0000-0003-3951-6365
et al (show 1 more authors) (2009) Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer BRITISH JOURNAL OF CANCER, 101 (1). pp. 139-144. ISSN 0007-0920, 1532-1827

[thumbnail of CYGB_accepted_version_may_2009.doc] Microsoft Word
CYGB_accepted_version_may_2009.doc - Author Accepted Manuscript

Download (215kB)
[thumbnail of 1178.pdf] PDF
1178.pdf - Published version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (141kB)

Abstract

Background:Cytoglobin (Cygb) was first described in 2002 as an intracellular globin of unknown function. We have previously shown the downregulation of cytoglobin as a key event in a familial cancer syndrome of the upper aerodigestive tract.Methods:Cytoglobin expression and promoter methylation were investigated in sporadic head and neck squamous cell carcinoma (HNSCC) using a cross-section of clinical samples. Additionally, the putative mechanisms of Cygb expression in cancer were explored by subjecting HNSCC cell lines to hypoxic culture conditions and 5-aza-2-deoxycitidine treatment.Results:In clinically derived HNSCC samples, CYGB mRNA expression showed a striking correlation with tumour hypoxia (measured by HIF1A mRNA expression P0.013) and consistent associations with histopathological measures of tumour aggression. CYGB expression also showed a marked negative correlation with promoter methylation (P0.018). In the HNSCC cell lines cultured under hypoxic conditions, a trend of increasing expression of both CYGB and HIF1A with progressive hypoxia was observed. Treatment with 5-aza-2-deoxycitidine dramatically increased CYGB expression in those cell lines with greater baseline promoter methylation.ConclusionWe conclude that the CYGB gene is regulated by both promoter methylation and tumour hypoxia in HNSCC and that increased expression of this gene correlates with clincopathological measures of a tumour's biological aggression. © 2009 Cancer Research UK.

Item Type: Article
Additional Information: Shaw, R J,Omar, M M,Rokadiya, S, Kogera, F A, Lowe, D, Hall, G L, Woolgar, J A; Homer, J, Liloglou, T, Field, J K, Risk, J M Research Support, Non-U.S. Gov't England British journal of cancer Br J Cancer. 2009 Jul 7;101(1):139-44. ## TULIP Type: Articles/Papers (Journal) ##
Uncontrolled Keywords: CYGB, head and neck squamous cell carcinoma, hypoxia, HIF1-a, methylation
Subjects: ?? RK ??
Divisions: Faculty of Health & Life Sciences > Inst. Life Courses & Medical Sciences > School of Dentistry
Depositing User: Symplectic Admin
Date Deposited: 02 Oct 2009 09:38
Last Modified: 16 Jun 2026 08:23
DOI: 10.1038/sj.bjc.6605121
Publisher's Statement : © 2009 Cancer Research UK . This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. First published in British Journal of Cancer (2009) 101, 139–144. doi:10.1038/sj.bjc.6605121 'Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer' R J Shaw, M M Omar, S Rokadiya, F A Kogera, D Lowe, G L Hall, J A Woolgar, J Homer, T Liloglou, J K Field, and J M Risk. http://dx.doi.org/10.1038/sj.bjc.6605121 .
Related Websites:
URI: https://livrepository.liverpool.ac.uk/id/eprint/1178
Disclaimer: The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.